Cervical myofascial pain syndrome. Myositis
Conditions
Interventions
Intervention 1: Intervention group: Group A: The respective gel (curcumin ) will be applied topically over the affected area at a dose of 2 grams., A therapeutic ultrasound device operating at 1 MHz
Sponsors
Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Individuals of all ages diagnosed with cervical myofascial pain syndrome Moderate to severe pain No contraindications to curcumin or naproxen.
Exclusion criteria
Exclusion criteria: Pregnancy , Lactation Severe cervical spine pathology, History of drug allergy, and prior treatment with corticosteroids or other anti-inflammatory medications within four weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 4 weeks. Method of measurement: NPRS.;Cervical ROM. Timepoint: 4 WEEKS. Method of measurement: Goniometry.;Muscle tenderness. Timepoint: 4 weeks. Method of measurement: Pressure pain threshold scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serological findings. Timepoint: 4 weeks. Method of measurement: ESR, CRP,IL-6.;Quality of life. Timepoint: 4 weeks. Method of measurement: SF-36 scale.;Functional Status. Timepoint: 4 weeks. Method of measurement: McGill Questionnaire. | — |
Countries
Pakistan
Contacts
Public ContactMaliha Khalid Khan
Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan.
Outcome results
None listed